Free Newsletter
FDA should guide, not regulate, online talk
Drug companies and their customers need to be able to converse online so they can correct misinformation, share product knowledge and learn together. While individual exchanges can't be regulated, the overall effort can be, says social media evangelist Bob Pearson. "We need industry and social media experts to provide innovative solutions to the FDA. We then need the FDA to create guidelines that can evolve with the medium, rather than place increasing restrictions on it." Article
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: